PXS4728A: Interim Phase I data

Interim data from 48 healthy volunteers in the double-blind, placebo-controlled, Australian Phase I PXS-4728A-101 trial showed that single doses of 1-20 mg oral PXS4728A led to no safety concerns. Dat...